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Abstract
Background and objective: Cerebral microembolism detected by transcranial Doppler (TCD) occurs systematically
during cardiac catheterization, but its clinical relevance, remains unknown. Studies suggest that asymptomatic embolic
cerebral infarction detectable by diffusion-weighted (DW) MRI might exist after percutaneous cardiac interventions with
a frequency as high as 15 to 22% of cases. We have set up, for the first time, a prospective multicenter trial to assess the
rate of silent cerebral infarction after cardiac catheterization and to compare the impact of the arterial access site,
comparing radial and femoral access, on this phenomenon.
Study design: This prospective study will be performed in patients with severe aortic valve stenosis. To assess the
occurrence of cerebral infarction, all patients will undergo cerebral DW-MRI and neurological assessment within 24
hours before, and 48 hours after cardiac catheterization and retrograde catheterization of the aortic valve.
Randomization for the access site will be performed before coronary angiography. A subgroup will be monitored by
transcranial power M-mode Doppler during cardiac catheterization to observe cerebral blood flow and track emboli.
Neuropsychological tests will also be recorded in a subgroup of patients before and after the interventional procedures
to assess the impact of silent brain injury on potential cognitive decline. The primary end-point of the study is a direct
comparison of ischemic cerebral lesions as detected by serial cerebral DW-MRI between patients explored by radial
access and patients explored by femoral access. Secondary end-points include comparison of neuropsychological test
performance and number of microembolism signals observed in the two groups.
Implications: Using serial DW-MRI, silent cerebral infarction rate will be defined and the potential influence of vascular
access site will be evaluated. Silent cerebral infarction might be a major concern during cardiac catheterization and its
potential relationship to cognitive decline needs to be assessed.
Study registration: The SCIPION study is registered through National Institutes of Health-sponsored clinical trials
registry and has been assigned the Identifier: NCT 00329979.
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Background
Acute cerebral infarction following cardiac catheterization
is rare [1-3], but silent brain injury could occur at an unex-
pectedly high rate [3-6] as detected by diffusion-weighted
(DW) magnetic resonance imaging (MRI). Indeed the
high sensitivity of DW-MRI suggests that this technique
could allow an improved estimate of cerebral ischemic
events associated with cardiovascular catheterization pro-
cedures and could be used therefore as a surrogate end-
point for risk assessment of stroke [7]. The use of
transcranial Doppler (TCD) sonography allows the
recording of microemboli entering the middle cerebral
artery during various endovascular interventions, includ-
ing cardiac catheterization [8,9]. In the case of coronary
bypass surgery, evidence indicates that microembolism
might be related to cognitive impairment, based on the
results of neuropsychological testing [10]. During cardiac
catheterization, cerebral microembolism as detected by
TCD has frequently been observed, but whether it is clin-
ically relevant remains unknown [8,9]. However, recent
studies mentioned above, have suggested that some of
these microemboli could be related to silent cerebral
embolisms responsible for acute ischemic brain injury, as
documented by DW-MRI [3-6]. Furthermore there is
increasing evidence that cumulative burden of ischemic
brain injury causes neuropsychological deficits or aggra-
vates vascular dementia [11]. Thus DW-MRI emerges as a
valuable diagnostic method for the monitoring of
periprocedural ischemic events in the brain and could be
considered as a surrogate parameter for optimising diag-
nostic and therapeutic vascular interventions.
In the present trial two vascular access sites (trans-radial
approach [TRA] and trans-femoral approach [TFA]) rou-
tinely used for cardiac catheterization and percutaneous
cardiovascular interevention (PCI) will be compared for
the risk of silent brain injury occurrence. Indeed TRA is
associated with fewer local complications and it has been
suggested that in particular right TRA, which avoids cross-
ing the aortic arch could reduce the risk of mobilization of
atherosclerotic plaque, present particularly within the aor-
tic arch as documented previously by several authors [12-
14]. However this risk of brain injury in relation to vascu-
lar access site remains largely debatable. Using DW-MRI
as a surrogate parameter for brain injury assessment we
propose a prospective evaluation of the occurrence of
silent brain lesions in patients randomized either to TRA
or TFA.
Design and methods
Study design
Prospective multicenter randomized trial (4 centers cur-
rently involved: 2 in France, 1 in Italy and 1 in Austria).
Study objectives
1. Assessment in a prospective multicenter trial of the rate
of silent brain injury after cardiac catheterization
2. Comparison of the TRA and the TFA on the occurrence
of new cerebral lesions as detected by DW-MRI
3. Implication of silent brain infarction(s) on potential
cognitive impairment
End points
(i) Primary end-point
Number of patients observed with new cerebral lesions
either symptomatic or not after cardiac catheterization as
detected by DW-MRI in each group (comparison of radial
and femoral access).
(ii) Secondary end-points
Impact of potential silent cerebral infarction on cognitive
impairement.
Number of microembolism signals observed at TCD
between the two groups.
Study population
Patients with severe aortic stenosis scheduled for cardiac
catheterization because of aortic valve stenosis to assess
coronary artery tree and aortic valve disease before surgery
will be prospectively and consecutively invited to partici-
pate in the study. After informed consent is obtained the
patient will be included. Exclusion criteria will be a con-
traindication to MRI or inability to give written informed
consent.
Cardiac catheterization
All patients will be examined clinically by a senior physi-
cian and assessed for any history of previous cerebral
embolism. Transthoracic echocardiography, 12-lead sur-
face electrocardiogram, and coronary angiography will be
performed for all patients. Cardiac catheterizations will be
undertaken by expert interventional cardiologists using a
standard Seldinger technique using 5 French (F) catheters
either by TRA or TFA according to randomization assign-
ment. Sheaths will be removed immediately after the pro-
cedure in all patients. Unfractionated heparin (50 iu/kg)
will be given intravenously to all patients at the beginning
of the procedure. Retrograde catheterization of aortic
valve will be attempted in a right oblique projection using
a long exchange guidewire (0.035 inch, 260 cm length to
ensure exchange of the pigtail catheter) using a left
amplatz 1 catheter or a right Judkins catheter [15]. During
attempts to cross the aortic valve, the wire will be regularly
withdrawn and cleaned and the catheter flushed every 2
minutes according to Grossman's recommendations [16].
When the pigtail catheter is placed in the left ventricle, theTrials 2007, 8:15 http://www.trialsjournal.com/content/8/1/15
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wire will be withdrawn and the catheter vigorously aspi-
rated and pressure measurements performed. After left
ventriculography, the catheter will be rapidly withdrawn
from the left ventricle into the ascending aorta with simul-
taneous pressure measurements. Maximum and mean
pressure gradients will be established. The duration of the
whole procedure and fluoroscopic time in all patients will
also be recorded.
Magnetic resonance imaging
MRI will be done within 24 hours before, and 48 hours
after, cardiac catheterization. MRI will be performed with
a 1.5 Tesla system. The imaging protocol will include a
DW single-shot spin echo echoplanar sequence acquired
in the Anterior Commissure-Posterior Commissure plane
with 24 contiguous sections (diffusion gradient b values
of 0 and 1000 s/mm2, repetition time TR 6000 ms, echo
time TE 120 ms, slice thickness 6 mm with no gap, matrix
of 128 × 128 pixels, and field of view of 240 mm); fluid
attenuated inversion recovery (FLAIR; TR/TE 10000/160
ms, TI 2200 ms); and T2-weighted turbo spin echo
sequences (TR/TE 3500/94 ms). For DW-MRI, the diffu-
sion gradients will be successively and separately applied
in three orthogonal directions for a total acquisition time
of 24 seconds. Trace images will then be generated and
apparent diffusion coefficient (ADC) maps calculated
with a dedicated software tool available on all recent MRI
machines. The image analysis will be performed inde-
pendently by two experienced neuroradiologists who will
be blinded to the clinical data and will be unaware of the
technical aspects of the angiographic cardiac procedure.
For analysis of DW-MRI, the neuroradiologists will be
asked to determine the presence, size, number, and vascu-
lar distribution of any focal diffusion abnormalities
(bright lesions) in a pattern consistent with embolic
lesions. Typical positive DW-MRI showing bright lesions
(cerebral infarct) in asymptomatic patients are shown in
Figures 1 and 2.
Transcranial Doppler
Transcranial Doppler studies for this work will be per-
formed in a subgroup of patients with the TCD power M-
mode Doppler (PMD) 100 (Spencer Technologies, Seat-
tle, WA), which calculates a PMD image concurrently with
a single-gate spectrogram as previously described with a
threshold of 2 MHz [17]. Bilateral power M-mode TCD
will be recorded during cardiac catheterization through
the temporal bones of patients with an automatic detec-
tion of microemboli. The PMD image shows depth from
the probe on the vertical axis, time on the horizontal axis,
and power of the Doppler shift signal at specific depths as
color intensity. Simultaneously, the direction of blood
flow is derived from the positive or negative mean value
of the Doppler shift signal at the particular depth. This
mean velocity information is used in the PMD image as
red, depicting flow toward the probe, and blue as flow
away from the probe.
Microembolic signals present a unique signature or
"track" in the PMD image, which defines them as repre-
senting emboli. These potential embolic tracks in the mid-
dle cerebral arteries (MCA, red) and the anterior cerebral
arteries (ACA, blue) PMD images have simultaneous spec-
trogram signatures. However, the spectrogram signatures
are restricted to the point in time that the PMD embolic
track crosses the gate depth associated with the spectro-
gram (yellow line). The potential MCA microembolus,
which moves toward the probe as time progresses, will
have a positively sloped track within the image consistent
with its movement direction. The ACA microembolus,
which moves away from the probe as time progresses, will
have a negatively sloped track within the image. High-
power/high-intensity, transient unidirectional signals cor-
respond to the definition of microembolic signature
approved by the Consensus Committee of the 9th Cere-
brovascular Hemodynamics Symposium [18]. Typical
recordings of microembolic signals during cardiac cathe-
terization are shown in Figure 3 and 4.
Neuropsychological assessment
Patients will undergo neuropsychological assessment
within 24 hours before, and 48 hours after, cardiac cathe-
terization. All patients with documented cerebral infarc-
Typical positive DW-MRI (diffusion weighted-MRI) in asymp- tomatic patient confirming a recent cerebral infarction  before catheterization Figure 1
Typical positive DW-MRI (diffusion weighted-MRI) in asymp-
tomatic patient confirming a recent cerebral infarction 
before catheterization.Trials 2007, 8:15 http://www.trialsjournal.com/content/8/1/15
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t
ion at DW-MRI will be asked to come back for a new neu-
ropsychological assessment at 1 year follow-up.
The aim of the cognitive testing is to provide clinical evi-
dence of potential cerebral damage after cardiac catheteri-
zation and to quantify this potential cognitive decline
allowing comparison of two groups of patients explored
either by radial or femoral approaches. The tests must be
sensitive enough to detect potential post-procedure cogni-
tive decline and also able to explore different brain areas.
Most of the neuropsychological tests that will be adminis-
tered have been reported to be sensitive to change after
CABG or PCI procedures [19] and will include: Digit Span
Forwards and Backwards, Trail making test A and B,
Wechsler Memory Scale visual reproduction test, Rey-
Osterrieth's figure test, Grober-Buschckle's test, Rey Audi-
tory Verbal Learning Test, Verbal fluency test, and Con-
frontation naming test.
Statistical analysis
Baseline characteristics of the study population will be
presented as counts and percents for categorical variables
and as mean ± SD for continuous variables. Kappa statistic
will be calculated to determine interobserver agreement.
The number of lesions in our population of patients
recruited will be estimated by the adjusted Wald interval
at 95% in accordance with the method recommended by
Agresti & Coull [20]. With small sample sizes, as recom-
Typical microembolism signals (MES) recorded during cardiac  catheterization Figure 4
Typical microembolism signals (MES) recorded during cardiac 
catheterization. Shower of MES during left ventriculography. 
By convention in our center upper part is for right carotid 
system and lower part for the left side.
Typical positive DW-MRI (diffusion weighted-MRI) in asymp- tomatic patient confirming a new lesion appeared after car- diac catheterization Figure 2
Typical positive DW-MRI (diffusion weighted-MRI) in asymp-
tomatic patient confirming a new lesion appeared after car-
diac catheterization.
Typical microembolism signals (MES) recorded during cardiac  catheterization Figure 3
Typical microembolism signals (MES) recorded during cardiac 
catheterization. Isolated MES during catheter manipulation. 
By convention in our center upper part is for right carotid 
system and lower part for the left side.Trials 2007, 8:15 http://www.trialsjournal.com/content/8/1/15
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mended we will use the mid-point of the adjusted Wald
interval instead of the observed proportion [21]. The sta-
tistical analyses will be performed using SPSS 10.0.7 soft-
ware (Chicago, IL, USA). The compound score for global
cognitive function will be constructed by calculating the
average of the z scores for all the above tests. Cognitive
decline will be calculated by subtracting the z scores for
memory performance, psychomotor speed, and global
cognitive function at follow-up from the z scores at base
line. All analyses will be adjusted for age, sex, and level of
education, as well as the interval between the two sets of
neuropsychological tests.
Sample size calculation
Based on a pilot study [6] we think that radial approach
will be associated with a median rate of 5.9% [0.01–
12.5;95%CI] of new lesions as detected by cerebral DW-
MRI. In patients with aortic stenosis explored by femoral
approach we expect a 23% [15–31;95%CI] rate of similar
events [3]. With randomization 1:1 an alpha risk of 5%
and beta risk of 20% we anticipate a sample size popula-
tion of 152 patients needed to demonstrate that radial
approach could be associated with better outcome con-
cerning the occurrence of silent cerebral infarctions (76
patients in each arm of the study).
Randomization
After informed consent, eligible patients are randomized
1:1 to a strategy of radial or femoral access. Randomiza-
tion will be performed at the catheterization laboratory
before coronary angiography, by means of randomization
list (sealed envelopes) prepared by blocks of 10 patients.
Discussion
According to previous studies, the rate of stroke after car-
diac catheterization ranges from 0.10 % to 0.40 % [22].
However, these studies on the risk of stroke after cardiac
catheterization have taken only manifest new neurologi-
cal deficits as complications. Clinically unapparent dam-
age potentially caused by microscopic air embolism or
silent thromboembolism, had not been taken into
account. With the advent of DW-MRI, which is very sensi-
tive in detecting acute ischemic lesions within hours after
onset [23], it has been shown that asymptomatic embolic
events are far more frequent than the apparent neurologi-
cal complication rate [3-6]. It seems that only the length
of the procedure or the procedural fluoroscopy time can
be independently associated with the risk of cerebral inf-
arction in these studies. These two parameters are related
to the overall influence of the catheter manipulation
including additional periods of time while the catheter
acts as a embolic source because it may lead to thrombus
formation or affect the vessel wall during manipulation or
placement in the patient's vascular system. It has also
been suggested that silent acute brain injury can be
increased using trans-radial access [5] but this has not
been demonstrated.
Because all cardiac catheterizations are associated with
microembolism as detected by TCD it has been suggested
that most of these microembolism might be microbub-
bles and are therefore likely to be benign. However some
recent publications, mentioned above, raise the possibil-
ity that some microparticles embolized during heart cath-
eterization could be responsible for acute brain injuries.
In fact, the most likely sources of embolic material are
catheters and guidewires that dislodge atheromatous
material from the aorta [24]. Visible aortic debris may be
seen upon withdrawal of catheters during PCI cases [25].
Patients with a large atherosclerotic burden in the aorta as
documented by transesophageal echocardiography, such
as those with advanced coronary artery disease, have an
increased risk of cardiac catheterization-induced stroke
[12]. It has been shown that patients with cardiac cathe-
terization-induced stroke often have multiple acute
lesions on DW-MRI (often tiny, cortical, and in different
vascular territories), distinct from the occasionally symp-
tomatic lesion, and consistent with a shower of embolic
material.
Silent cerebral infarction might be a major concern during
cardiac catheterization and its potential relationship with
cognitive decline needs to be assessed prospectively in a
multicenter study. In the SCIPION trial we will use serial
DW-MRI to assess the rate of silent cerebral infarction
after cardiac catheterization and we will compare the
impact of the arterial access site (radial or femoral) on this
emerging phenomenon.
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